New registry study aims to improve sepsis treatment with ARTICE® therapy
Disease control
Recruiting now
This study is collecting real-world data from 200 adults with sepsis or septic shock who receive ARTICE® therapy in the ICU. Researchers will track organ function, lab markers, survival, and complications to better understand how well the treatment works and who benefits most. Th…
Sponsor: Artcline GmbH • Aim: Disease control
Last updated May 17, 2026 05:06 UTC